Juthani, R., Parab, P., Seetharaman, K. (2025). Inclusion of patients with reduced performance status (ECOG 2 or higher) in FDA registrational trials for renal cell carcinoma (RCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.453